The study involves blood samples from patients with Ewing's sarcoma to identify circulating biomarkers as a tool for the preclinical validation of innovative therapeutic approaches
Male and female patients of any age diagnosed with Ewing sarcoma.
Signed, study-specific informed consent form for the BIOVES study (cancer patients)
Male and female patients of legal age without a cancer diagnosis.
Signed, study-specific informed consent form for the BIOVES study (non-cancer patients)
None
The study aims to enroll patients of any gender who are being treated at the Rizzoli Orthopedic Institute in the following departments: Orthopedic and Traumatology Clinic III (with a primary focus on oncology), General and Thoracic Surgery (for both cancer and non-cancer patients), and Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies (for cancer patients only).
Case-control
Prospective
one blood sample
Other interventionnon onco
3 blood samples
Other interventiononco
characterisation of circulating biomarkers
search for circulating biomarkers from blood samples taken at three different time points
Click on the lead sponsor to view all of their trials.
